Innovating to beat cancer
Imagen was founded by two ex-AstraZeneca cell-biologists, leaders in the field of high content screening who pioneered research in systems biology and applications in personalised medicine.
Imagen’s vision of developing an accurate method of modelling cancer tumours in the lab culminated with the development of the predictRx platform. To date we’ve modelled over 150,000 patient treatments.
Together with experienced industry entrepreneurs, Imagen has grown to become a global provider of services to the pharmaceutical drug development industry through the launch of the predictTx platform.
Everything we do is informed by our unending drive to transform patient outcomes.
We are passionate about improving outcomes for cancer patients
We are driven by science, belief and ethics and seek to innovate
We are supportive and consultative, and work as a community
We continuously strive to learn, develop, and grow
Company registered in England and Wales with Company Registration No: 06373341
Full legal name: IMAGEN THERAPEUTICS LIMITED
Registered office address: C/O Mckellens 11 Riverview, The Embankment Bus Pk, Vale Road Heaton Mersey, Stockport, SK4 3GN
VAT number: GB 921 606 446
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
